Infigratinib versus gemcitabine plus cisplatin multicenter, open-label, randomiz

Discussion Board › Forums › Chemotherapy & More › Infigratinib versus gemcitabine plus cisplatin multicenter, open-label, randomiz

Viewing 1 post (of 1 total)
  • Author
    Posts
  • May 15, 2019 at 3:04 pm #98566
    gavin
    Moderator

    Infigratinib versus gemcitabine plus cisplatin multicenter, open-label, randomized, phase 3 study in patients with advanced cholangiocarcinoma with FGFR2 gene fusions/translocations: The PROOF trial.

    http://abstracts.asco.org/239/AbstView_239_261865.html

  • Author
    Posts
Viewing 1 post (of 1 total)
  • The forum ‘Chemotherapy & More’ is closed to new topics and replies.